Thus, lowered neutrophil counts and concomitants reduction in MMP-9-positive tumor tissue cells together with increased Granzyme B-positive tumor-associated cells, reflect the anti-cancer mechanisms of AAT augmentation therapy. Here, GZMB is linked to cancer.